☆ 4.7 Meeting Abstract

Treatment with tumor-infiltrating lymphocytes (TIL) versus ipilimumab for advanced melanoma: Results from a multicenter, randomized phase III trial

ANNALS OF ONCOLOGY (2022)

Get Full Text
Add to Collection

Journal

ANNALS OF ONCOLOGY
Volume 33, Issue 7, Pages S1406-S1406

Publisher

ELSEVIER
DOI: 10.1016/j.annonc.2022.08.036

Keywords

-

Categories

Oncology

Funding

  1. Dutch Cancer Society
  2. Netherlands Organization for Health Research and Development
  3. Dutch Ministry of Health
  4. Stichting Avento
  5. Copenhagen University Hospital
  6. Herlev
  7. Danish Cancer Society
  8. Capital Region of Denmark Research Foundation

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.